Efficacy and Safety of Ustekinumab for Ulcerative Colitis Through 3 Years: UNIFI Long-term Extension

被引：0
|
作者：
Abreu, M. T.
Danese, S.
Sandborn, W. J.
Miao, Y.
Tikhonov, I.
Zhang, H.
Panacciones, R.
Hisamatsu, T.
Scherl, E. J.
Leong, R. W.
Rowbotham, D. S.
Arasaradnam, R. P.
Afif, W.
Peyrin-Biroulet, L.
Sands, B. E.
Marano, C.
机构：
来源：
JOURNAL OF CROHNS & COLITIS | 2021年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
DOP83
引用
收藏
页码：S113 / S114
页数：4
相关论文
共 50 条
  • [41] Ustekinumab maintained clinically meaningful improvement in health-related quality of life in patients with moderate to severe ulcerative colitis: Results from the UNIFI long-term extension
    Sandborn, W. J.
    Rowbotham, D. S.
    Leong, R. W. L.
    Han, C.
    Zhou, Y.
    Zhang, H.
    Johanns, J.
    Marano, C.
    Danese, S.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S094 - S095
  • [42] Long-term Efficacy of Vedolizumab for Ulcerative Colitis
    Loftus, Edward V., Jr.
    Colombel, Jean-Frederic
    Feagan, Brian G.
    Vermeire, Severine
    Sandborn, William J.
    Sands, Bruce E.
    Danese, Silvio
    D'Haens, Geert R.
    Kaser, Arthur
    Panaccione, Remo
    Rubin, David T.
    Shafran, Ira
    McAuliffe, Megan
    Kaviya, Arpeat
    Sankoh, Serap
    Mody, Reema
    Abhyankar, Brihad
    Smyth, Michael
    JOURNAL OF CROHNS & COLITIS, 2017, 11 (04): : 400 - 411
  • [43] Effect of Ustekinumab Maintenance Therapy on Stool Frequency and Rectal Bleeding Through 2 Years in the UNIFI Phase 3 Study in Ulcerative Colitis
    Abreu, Maria T.
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    Marano, Colleen
    Zhou, Yiying
    Zhang, Hongyan
    Leong, Rupert W. L.
    Rowbotham, David
    Panaccione, Remo
    Sandborn, William J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S398 - S398
  • [44] DOSE ADJUSTMENT IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS: RESULTS FROM THE UNIFI MAINTENANCE STUDY LONG-TERM EXTENSION
    Sands, Bruce E.
    Panaccione, Remo
    Peyrin-Biroulet, Laurent
    Marano, Colleen W.
    O'Brien, Christopher D.
    Zhang, Hongyan
    Zhou, Yiying
    Johanns, Jewel
    Scherl, Ellen J.
    Leong, Rupert W.
    Rowbotham, David
    Arasaradnam, Ramesh P.
    Danese, Silvio
    GASTROENTEROLOGY, 2020, 158 (06) : S1204 - S1204
  • [45] Long-term efficacy and safety of ustekinumab in patients with moderate to severe psoriasis through 5 years of follow-up: results from the PHOENIX 1 long-term extension
    Kimball, A. B.
    Papp, K. A.
    Wasfi, Y.
    Chan, D.
    Bissonnette, R.
    Sofen, H.
    Yeilding, N.
    Li, S.
    Szapary, P. O.
    Gordon, K. B.
    BRITISH JOURNAL OF DERMATOLOGY, 2012, 167 : 63 - 64
  • [46] Long-Term Safety and Efficacy of Fecal Microbiota Transplant in Active Ulcerative Colitis
    Xiao Ding
    Qianqian Li
    Pan Li
    Ting Zhang
    Bota Cui
    Guozhong Ji
    Xiang Lu
    Faming Zhang
    Drug Safety, 2019, 42 : 869 - 880
  • [47] Long-Term Safety and Efficacy of Fecal Microbiota Transplant in Active Ulcerative Colitis
    Ding, Xiao
    Li, Qianqian
    Li, Pan
    Zhang, Ting
    Cui, Bota
    Ji, Guozhong
    Lu, Xiang
    Zhang, Faming
    DRUG SAFETY, 2019, 42 (07) : 869 - 880
  • [48] Efficacy and Safety of Ustekinumab for Crohn's Disease Through 5 Years: Final Results From the IM-UNITI Long-Term Extension
    Sandborn, William J.
    Rutgeerts, Paul
    Lynch, John
    Rebuck, Rory
    Wang, Yuhua
    Zou, Bin
    Gasink, Christopher
    Adedokun, Omoniyi
    Sands, Bruce E.
    Hanauer, Stephen
    Targan, Stephan
    Ghosh, Subrata
    de Villiers, Willem J. S.
    Colombel, Jean-Frederic
    Feagan, Brian G.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S323 - S324
  • [49] Dose adjustment in patients with moderate-to-severe ulcerative colitis: results from the UNIFI maintenance study long-term extension
    Danese, S.
    Panaccione, R.
    Peyrin-Biroulet, L.
    Marano, C.
    O'Brien, C. D.
    Zhang, H.
    Zhou, Y.
    Johanns, J.
    Scherl, E.
    Leong, R. W. L.
    Rowbotham, D. S.
    Arasaradnam, R. P.
    Sands, B. E.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S403 - S403
  • [50] Long term efficacy and safety of ustekinumab in patients with moderate to severe psoriasis through 5 years of follow-up: results from the PHOENIX 1 long-term extension
    Papp, K.
    Kimball, A.
    Wasfi, Y.
    Chan, D.
    Bissonnette, R.
    Sofen, H.
    Yeilding, N.
    Li, S.
    Szapary, P.
    Gordon, K.
    JOURNAL OF DERMATOLOGY, 2012, 39 : 239 - 240
12345